Novonesis A/S is a Danish biosolutions and industrial biotechnology company formed in 2024 through the combination of Novozymes and Chr. Hansen. The company researches, develops, and manufactures enzymes, microbial cultures, and other bio-based ingredients used across food and beverages, household care and cleaning, agriculture and animal health, bioenergy, and various industrial applications.
Using advanced fermentation, protein engineering, and microbial science, Novonesis supplies specialty inputs designed to enhance process efficiency, product performance, and resource use. The company operates R&D centers, application laboratories, and production sites globally, providing both established product portfolios and tailored solutions within relevant regulatory frameworks. As a Danish public limited company (A/S), Novonesis focuses on scaling biotechnology to replace or complement traditional chemical processes in areas such as baking, dairy, brewing, plant and animal nutrition, detergents, textiles, and renewable fuels.
None yet. When a new project in the record names Novonesis A/S as owner, partner or investor, it shows here.
A consortium progresses to phase two, optimizing CO2-to-food tech with renewed funding, aiming to create sustainable protein alternatives amid global hunger challenges.
